| Amy B Turner, DO | |
|
1 Nolte Dr Medical Arts Bldg 200, Suite 230, Kittanning, PA 16201-7111 | |
| (724) 543-2229 | |
| (724) 545-3452 |
| Full Name | Amy B Turner |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 1 Nolte Dr Medical Arts Bldg 200, Kittanning, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942526793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS015121 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Clair Hospital | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Women's Care Of Pittsburgh, P.c. | 0547225245 | 8 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
As the latest statistics estimate that worldwide one billion adults are overweight, and a third of those are obese, an expert has stated that the issue must be regarded with the same urgency as climate change.
Children who are vitamin D deficient have a greater risk of having more severe forearm fractures requiring surgical treatment, according to a new study presented today at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons.
Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease.
Health 2.0 Accelerator, a consortium focused on promoting integration of technology and the consumer experience to advance consumer-centric health care, announced today that Kaiser Permanente will join other "Health 2.0 companies" as participants in the Health 2.0 Accelerator (http://h2anetwork.org).
› Verified 3 days ago
| Entity Name | Advanced Women's Care Of Pittsburgh, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265574925 PECOS PAC ID: 0547225245 Enrollment ID: O20041122000962 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
As the latest statistics estimate that worldwide one billion adults are overweight, and a third of those are obese, an expert has stated that the issue must be regarded with the same urgency as climate change.
Children who are vitamin D deficient have a greater risk of having more severe forearm fractures requiring surgical treatment, according to a new study presented today at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons.
Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease.
Health 2.0 Accelerator, a consortium focused on promoting integration of technology and the consumer experience to advance consumer-centric health care, announced today that Kaiser Permanente will join other "Health 2.0 companies" as participants in the Health 2.0 Accelerator (http://h2anetwork.org).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy B Turner, DO 1 Nolte Dr Medical Arts Bldg 200, Suite 230, Kittanning, PA 16201 Ph: (724) 543-2229 | Amy B Turner, DO 1 Nolte Dr Medical Arts Bldg 200, Suite 230, Kittanning, PA 16201-7111 Ph: (724) 543-2229 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
As the latest statistics estimate that worldwide one billion adults are overweight, and a third of those are obese, an expert has stated that the issue must be regarded with the same urgency as climate change.
Children who are vitamin D deficient have a greater risk of having more severe forearm fractures requiring surgical treatment, according to a new study presented today at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons.
Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease.
Health 2.0 Accelerator, a consortium focused on promoting integration of technology and the consumer experience to advance consumer-centric health care, announced today that Kaiser Permanente will join other "Health 2.0 companies" as participants in the Health 2.0 Accelerator (http://h2anetwork.org).
› Verified 3 days ago
Dr. Yanouchka D Narcisse, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Medical Arts Bldg, Suite 300, Kittanning, PA 16201 Phone: 724-543-8784 Fax: 724-543-8764 | |
Dr. Jeffrey W David, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Arts Bldg, Suite 540, Kittanning, PA 16201 Phone: 724-543-8378 Fax: 724-543-8379 |